Caplyta

Generic name: Lumateperone
Drug class: Atypical antipsychotics

Usage of Caplyta

Caplyta (lumateperone) is used in adults to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions).

Caplyta is also used alone or with lithium or valproate to treat depression associated with bipolar disorder (manic depression).

Caplyta belongs to a class of medications called atypical antipsychotics. The exact way lumateperone works is unknown but it is thought to change the activity of certain natural substances in the brain.

Caplyta side effects

Get emergency medical help if you have signs of an allergic reaction ro Caplyta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

People with depression or mental illness may have thoughts about suicide. Some young people may have increased suicidal thoughts when first starting a medicine to treat depression. Stay alert to changes in your mood or symptoms. Your family or caregivers should also watch for sudden changes in your behavior.

High doses or long-term use of Caplyta can cause a serious movement disorder that may not be reversible. The longer you use Caplyta, the more likely you are to develop this disorder, especially if you are a woman or an older adult.

Caplyta may cause serious side effects. Call your doctor at once if you have:

feeling unsteady, feeling like you might pass out;

uncontrolled muscle movements in your face (chewing, lip smacking, frowning, tongue movement, blinking or eye movement);

tightness in your neck or throat, trouble swallowing;

trouble breathing or speaking;

a seizure;

high blood sugar - increased thirst, increased urination, dry mouth, fruity breath odor;

low white blood cell counts - fever, chills, mouth sores, skin sores, sore throat, cough, trouble breathing; or

severe nervous system reaction - very stiff (rigid) muscles, high fever, sweating, confusion, fast or uneven heartbeats, tremors, feeling like you might pass out.

Common Caplyta side effects may include:

nausea;

dizziness;

drowsiness; or

dry mouth.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Caplyta

You should not use Caplyta if you are allergic to lumateperone.

Lumateperone may increase the risk of death in older adults with dementia-related psychosis and is not approved for this use.

To make sure Caplyta is safe for you, tell your doctor if you have ever had:

heart problems or a stroke;

high or low blood pressure;

seizures;

trouble swallowing;

low white blood cell count;

high cholesterol or triglycerides;

diabetes or high blood sugar, or a family history of diabetes or high blood sugar; or

liver or kidney disease.

Taking antipsychotic medicine in the last 3 months of pregnancy may cause serious problems in the newborn. Tell your doctor right away if you get pregnant. Do not stop the medicine without your doctor's advice.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of lumateperone on the baby.

You should not breastfeed while using Caplyta.

This medicine may affect fertility (your ability to have children), whether you are a man or a woman.

Relate drugs

How to use Caplyta

Usual Adult Dose for Schizophrenia:

42 mg orally once a day Use: For the treatment of schizophrenia

Usual Adult Dose for Bipolar Disorder:

42 mg orally once a day Use: As monotherapy or as adjunctive therapy with lithium or valproate, for the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression)

Warnings

Caplyta is not approved for use in older adults with dementia-related psychosis. Caplyta can increase the risk of death in elderly people who have lost touch with reality (psychosis) due to confusion and memory loss (dementia).

People with depression or mental illness may have thoughts about suicide. Some young people may have increased suicidal thoughts when first starting a medicine to treat depression. Tell your doctor right away if you have any sudden changes in mood or behavior, or thoughts about suicide.

What other drugs will affect Caplyta

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Tell your doctor about all your current medicines. Many drugs can interact with lumateperone, especially:

an antibiotic, antifungal, or antiviral medicine;

blood pressure medication;

bronchodilator asthma medication;

cold or allergy medicine (Benadryl and others);

medicine to treat depression, anxiety, mood disorders, or mental illness;

medicine to treat overactive bladder;

medicine to treat Parkinson's disease;

medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

seizure medicine; or

St. John's wort.

This list is not complete and many other drugs may interact with lumateperone. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Popular FAQ

Caplyta (lumateperone) treatment is not associated with the weight gain that some other antipsychotic drugs are. Caplyta is an atypical antipsychotic that is used to treat schizophrenia and bipolar depression in adults. Results from a number of trials combined together showed that the weight gain observed in patients treated with Caplyta was similar to the weight gain observed in patients who received placebo. Positive results were also reported by a study that followed patients for one year after they switched from standard of care to Caplyta. Significant improvements in mean body weight were observed during the year of treatment (-2.1 kg, P <0.001) when mean body weights from the beginning and end of the year were compared. Significant reductions in body mass index (BMI) and waist circumference were also observed.

Caplyta (lumateperone) should be taken once a day with or without food. The recommended dosage is one 42mg capsule a day. Caplyta can cause somnolence and sedation, but these side effects are reported less frequently when Caplyta is taken in the evening.

Patient with schizophrenia started to show improved Positive and Negative Syndrome Scale (PANSS) total scores after one week of treatment with Caplyta (lumateperone), according to the results of a phase III trial. PANSS is a scale used to measure the severity of schizophrenia symptoms. Symptoms continue to improve the longer you take the drug. While there may be some signs of improvement during the initial weeks of treatment, it can take up to 2-3 months for the full effects to be felt in patients with schizophrenia. In the first 1-2 weeks, hallucinations, disorganized thinking and delusions may improve, although sometimes they won’t go away altogether. It can also take at least 1-2 weeks for motivation and the desire to be around other people to improve. Patients with bipolar depression also started to show improvement in their symptoms during the initial weeks of treatment with Caplyta, according to the results of another phase III trial. At the end of the 6 week trial, patients with bipolar depression treated with Caplyta 42mg day showed a statistically significant improvement in their symptoms compared with patients receiving placebo.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.